Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yixin Sim is a specialized contract research organization (CRO) and technology provider based in Beijing, China, focusing on Model-Informed Drug Development (MIDD) and quantitative pharmacology. As a member of the Yixin Healthcare Group, the company provides a comprehensive suite of services including population pharmacokinetics (PopPK), PK/PD modeling, physiologically based pharmacokinetic (PBPK) modeling, and clinical trial simulation. Yixin Sim supports pharmaceutical and biotechnology companies in optimizing drug development programs through data-driven insights, dose-finding strategies, and regulatory submission support. The company is also a prominent partner for industry-standard software providers like Certara, offering specialized training and technical support to the Chinese life sciences community. Their expertise spans various therapeutic areas, with a strong focus on oncology, immunology, and rare diseases, helping clients navigate complex clinical pharmacology requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yixin Sim.